Industry Trend Analysis - Baxalta Acquisition Bearing Fruit For Shire - 22 MAY 2017
Corporate Financing week May 2017 / Ireland / Industry
Strong organic growth from Shire's legacy products and the contribution from Baxalta's product sales expedited a solid commercial performance in Q117. Shire remains on track to deliver its impressi...
Industry Trend Analysis - Core Growth Drivers Deliver Impressive Sales Returns For Bayer - 22 MAY 2017
Corporate Financing week May 2017 / Germany / Industry
Bayer's better-than-expected Q117 financial results bode well for the company's outlook for 2017. Growth was largely driven by consistently strong business developments within the pharmaceuticals...
Industry Trend Analysis - Slowdown In Pharmaceutical Sales To Be Offset By Actelion Acquisition - 01 MAY 2017
Corporate Financing week April 2017 / United States / Industry
Johnson & Johnson's pharmaceutical business continues to dominate the firm's income statements; however, first quarter results for 2017 have highlighted the increasing challenges it will...
Industry Trend Analysis - Acquisition Bids Highlight Strength Of Stada's Business - 13 MAR 2017
Corporate Financing week March 2017 / Germany / Industry
Potential interest in acquiring Stada Arzneimittel has been building for almost a year, and has now come into the open with these three initial bids. Interest from other firms is certainly a possib...
Industry Trend Analysis - Azaya Acquisition Will Benefit Cytori's Cell Therapy Pipeline - 06 MAR 2017
Corporate Financing week March 2017 / United States / Industry
Cytori's acquisition of Azaya Therapeutics will provide the company with a nanoparticle platform that it can apply to its current pipeline to aid in delivery. The two near-to-market oncology compou...
Industry Trend Analysis - Privatisation Of Local Drugmakers To Enhance Their Competitive Position - 01 AUG 2016
Corporate Financing week July 2016 / Vietnam / Industry
Vietnam's domestic pharmaceutical companies will present a growing competitive threat to multinational firms operating in the South East Asian country. This has been accentuated as the authorities...
Industry Trend Analysis - Medivation Trying To Ignite Bidding War - 25 JULY 2016
Corporate Financing week July 2016 / United States / Industry
A bidding war will likely ensue after Medivation has essentially put itself up for sale. Sanofi could eventually conquer Medivation, but a challenge from Pfizer is probable. Xtandi appears to be...
Industry Trend Analysis - Sagent Acquisition A Logical Next Step For Nichi-Iko - 25 JULY 2016
Corporate Financing week July 2016 / Japan / Industry
Nichi-Iko Pharmaceutical's attention on the US market is a reminder that the US remains by far the largest market in the world for both originator and generic pharmaceuticals. Whilst Japan is the...
Industry Trend Analysis - Lupin On Course To Cement Place In US Market - 14 MAR 2016
Corporate Financing week March 2016 / India / Industry
US FTC consent for Lupin's proposed acquisition of Gavis Pharmaceuticals brings the acquisition a step closer to completion, and with only two products to be divested, the acquisition will be a...
Industry Trend Analysis - Hikma On Track To Boost US Generic Injectables Presence - 07 MAR 2016
Corporate Financing week March 2016 / United States / Industry
Despite the divestitures required by the FTC, Hikma's ongoing acquisition of what was essentially Boehringer Ingelheim's entire generics business will serve to substantially increase Hikma's positi...